$ITRX InTerra Resources Corp. announces acquisition of Helica, LLC., a biopharmaceutical product distribution firm, with exclusive distribution licenses from Sol Biotech, LLC.,Press Release | 05/24/2022
InTerra Resources Corp. (OTC: ITRX) announces acquisition of Helica, LLC. (Helica), a biopharmaceutical product distribution firm, with exclusive distribution licenses from Sol Biotech, LLC., which is focused on RNA viruses, including fusion inhibitors and immune-boosting nutritional supplements.
Following the combination, the Company elected new officers and directors as follows:
Robert Altermatt President and CEO
Chanda Zaveri Chief Scientific Officer, Ms Zaveri is currently the President and CEO of Sol Biotech.
Frank I Igwealor Chief Financial Officer.
The deal is expected to close in Q2, 2022, after which, InTerra Resources Corp., through Helica, will engage in marketing and distribution of biopharma products developed by Chanda Zaveri under the company name of Sol Biotech. Chanda Zaveri is the President and CEO of Sol Biotech and Robert Altermatt serves as a research scientist at Sol Biotech. The pair of Chanda and Bob have been working to expand the application of dietary supplements developed by Chanda Zaveri and formulated to combat the effects of RNA viral infections. Helica has been granted exclusive distribution rights throughout the continent of Africa for a Sol Biotech product line under the trade name of Virucine-C.
About Helica, LLC.
Helica, LLC is a California limited liabilities Company that will serve as a subsidiary of InTerra Resources Corp. Robert Altermatt is the President and CEO of Helica, LLC.
About InTerra Resources Corp.
InTerra Resources Corp., a Nevada Corporation was originally incorporated as Argent Investments, Inc. on October 29, 1998. On August 16, 2004, the Company changed its name to China Resources Group, Ltd. before changing it again on October 20, 2006, to InTerra Resources Corp. The company operations have historically focused on opportunistic acquisition and development of business interest in its field of interest.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
Invest@cbdxfund.com
